Immuneering
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $-94,419 |
Gross Profit | -175 | -187 | -94,604 |
EBITDA | -14,815 | -15,228 | -14,898 |
EBIT | -14,913 | -15,415 | -15,083 |
Net Income | -14,079 | -14,307 | -15,083 |
Net Change In Cash | 0 | 0 | -94,419 |
Free Cash Flow | -11,558 | -15,528 | -11,946 |
Cash | 59,728 | 66,287 | 59,405 |
Basic Shares | 29,653 | 29,370 | 29,269 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $ | $316 | $2,079 | $2,311 |
Gross Profit | -764 | 158 | 926 | 1,031 |
EBITDA | -58,060 | -51,467 | -33,726 | -17,003 |
EBIT | -58,412 | -52,264 | -33,886 | -17,082 |
Net Income | -53,471 | -49,281 | -33,535 | -17,039 |
Net Change In Cash | 316 | 2,079 | 2,311 | |
Cost of Revenue | -2,251 | 37,797 | ||
Free Cash Flow | -49,311 | -44,843 | -30,911 | -14,674 |
Cash | 59,405 | 72,636 | 74,888 | 37,090 |
Basic Shares | 28,416 | 26,386 | 26,320 | 25,514 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.49 |
2024-06-30 | -$0.47 |
2024-03-31 | -$0.49 |
2023-12-31 | -$0.52 |
